Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Current Assets: 2016-2025

Historic Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to $494.8 million.

  • Rhythm Pharmaceuticals' Current Assets rose 45.38% to $494.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.8 million, marking a year-over-year increase of 45.38%. This contributed to the annual value of $374.2 million for FY2024, which is 21.39% up from last year.
  • Rhythm Pharmaceuticals' Current Assets amounted to $494.8 million in Q3 2025, which was up 37.19% from $360.7 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Current Assets high stood at $494.8 million for Q3 2025, and its period low was $235.8 million during Q1 2024.
  • Its 3-year average for Current Assets is $342.9 million, with a median of $340.3 million in 2024.
  • In the last 5 years, Rhythm Pharmaceuticals' Current Assets surged by 59.89% in 2021 and then tumbled by 38.50% in 2022.
  • Over the past 5 years, Rhythm Pharmaceuticals' Current Assets (Quarterly) stood at $308.4 million in 2021, then grew by 14.87% to $354.2 million in 2022, then dropped by 12.98% to $308.3 million in 2023, then increased by 21.39% to $374.2 million in 2024, then surged by 45.38% to $494.8 million in 2025.
  • Its Current Assets stands at $494.8 million for Q3 2025, versus $360.7 million for Q2 2025 and $369.3 million for Q1 2025.